Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2005
12/01/2005US20050267027 Use of erythropoietin for treatment of cancer
12/01/2005US20050267025 Compositions and methods for treatment of infectious and inflammatory diseases
12/01/2005US20050267024 Polypeptide, cancer therapy, neovascularization defects, retinopathies, arthritis and psoraisis
12/01/2005US20050267022 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
12/01/2005US20050267016 Therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle
12/01/2005US20050266579 Assay system with in situ formation of diazo reagent
12/01/2005US20050266578 Methods and systems for detection of macrolides
12/01/2005US20050266577 Ultrafiltration device for drug binding studies
12/01/2005US20050266576 By identifying proteins associated with sudden cardiac death (SCD); ventricular tachyarrhythmia; biomarkers
12/01/2005US20050266575 Pharmacophores for nociceptin, methods of obtaining and using in screening for nociceptin mimics
12/01/2005US20050266574 for measuring creatinine as an indicator of kidney function in the field of clinical care ; measurement can be performed quickly and easily; contains 2,6-dichloro-4'-hydroxy-3',3''-dimethyl-3-sulfofuchsone-5',5''-dicarboxylic acid trisodium salt and a metal that forms a colored complex with the compound
12/01/2005US20050266573 Mixture of synthetic microsphere polystyrene or carboxylated polystyrene particles, monodispersed suspensions containing surfactants, and erythrocytes, leukocytes, platelets or reticulocytes, used for analyzing maturity of blood cells; cytometry; optics
12/01/2005US20050266572 Method for marking hydrocarbons with substituted anthraquinones
12/01/2005US20050266571 Method for feedback control of a microfluidic system
12/01/2005US20050266553 Methods of regulating differentiation in stem cells
12/01/2005US20050266552 Reagents and methods for identification of RNAi pathway genes and chemical modulators of RNAi
12/01/2005US20050266524 Beta integrin gene and protein
12/01/2005US20050266515 Glyceraldehyde 3-phosphate dehydrogenase-S (GAPDHS), a glycolytic anzyme expressed only in male germ cells, is a target for male contraception
12/01/2005US20050266514 used to quickly diagnose infections with gram-negative bacteria (as Escherichia coli) or with fungi (as Candida albicans)
12/01/2005US20050266511 High throughput sarcomeric assay
12/01/2005US20050266510 T cell anergy is reversed by active Ras and regulated by diacylglycerol kinase
12/01/2005US20050266509 Interaction of NMDA receptor with protein tyrosine phosphatase
12/01/2005US20050266507 Antibody pair screening methods
12/01/2005US20050266506 Method for diagnosing or monitoring carbohydrate metabolism disorders
12/01/2005US20050266505 Compound with a hydroxamate and a benzophenone group, and a functional group of rhodamine, oligonucleotides, azides, alkynes, biotin, or p-nitrophenyl; binding the active compound to the active site, forming an active compound-metalloprotease adduct; determining the potency of the inhibitor
12/01/2005US20050266504 Diagnosing nervous system disorders; obtain tissue sample, measure expression of semaphorin 3 and downstream effectors , amplified concentrations of semaphorins indicate nervous system disorders; drug screening
12/01/2005US20050266503 Simultaneous assay of target and target-drug binding
12/01/2005US20050266502 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/01/2005US20050266501 Reagent for detecting risk factor of alzheimer's disease, detection kit therefor and method of detecting risk factor of alzheimer's disease using the same
12/01/2005US20050266500 By measuring paratope (binary surfaces which bind detectable reporters) signals; immunoassays; spectrum analysis
12/01/2005US20050266499 Method and apparatus for testing for presence or absence of select biological substances
12/01/2005US20050266498 Method for screening biomolecule activity regulator
12/01/2005US20050266497 by determining the level of small proline-rich protein 3 (SPRR3)protein; biomarkers
12/01/2005US20050266495 Method and program for library generation
12/01/2005US20050266494 System and method for computer network ordering of biological testing
12/01/2005US20050266490 Using membrane protein as tool in identifying modulators for prevention and treatment of cell proliferative, autoimmune, inflammatory, nervous system and metabolic disorders
12/01/2005US20050266486 Methods for treating obesity by inhibiting expression of obese gene product receptor variant
12/01/2005US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer
12/01/2005US20050266483 Novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
12/01/2005US20050266479 Cloning, expression and characterization of the SPG4 gene responsible for the most common form of autosomal dominant spastic paraplegia
12/01/2005US20050266478 Biochips including ion transport detecting structures and methods of use
12/01/2005US20050266477 Reagents and methods useful for detecting diseases of the gastrointestinal tract
12/01/2005US20050266476 Dual bead assays including covalent linkages for improved specificity and related optical analysis discs
12/01/2005US20050266475 Method for determining an analyte
12/01/2005US20050266472 Apparatus and method for detecting bio molecule using inductance device
12/01/2005US20050266470 25501, a human transferase family member and uses therefor
12/01/2005US20050266467 Biomarkers for multiple sclerosis and methods of use thereof
12/01/2005US20050266461 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/01/2005US20050266450 Method for analyzing a target nucleic acid fragment and a kit for analyzing a target nucleic acid fragment
12/01/2005US20050266449 Method of detecting a hybrid, formed of at least two species, on a substrate
12/01/2005US20050266443 Novel tumor suppressor gene and compositions and methods for making and using the same
12/01/2005US20050266437 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
12/01/2005US20050266435 VR1 receptors and uses thereof
12/01/2005US20050266433 Magnetic device for isolation of cells and biomolecules in a microfluidic environment
12/01/2005US20050266430 A mutated G-CSF mRNA or cDNA fragment having a deletion of an exon 3 region for use; primer for use in amplification of a G-CSF gene
12/01/2005US20050266427 Biomolecule/polymer conjugates
12/01/2005US20050266425 Methods for producing and identifying multispecific antibodies
12/01/2005US20050266424 Real-time sequence determination
12/01/2005US20050266420 Multigene predictors of response to chemotherapy
12/01/2005US20050266415 Method for sampling gas-borne matter
12/01/2005US20050266412 Method of amplifying infectious protein
12/01/2005US20050266411 Methods for rapid forensic analysis of mitochondrial DNA
12/01/2005US20050266410 Methods of Human Leukocyte Antigen typing by neighboring single nucleotide polymorphism haplotypes
12/01/2005US20050266409 Compositions and methods for diagnosing, preventing, and treating cancers
12/01/2005US20050266408 used in linkage analysis to track disease genes in human pedigrees or economically important traits in animal and plant breeding programmes; forensic and paternity testing; to discover mutations in biologically and clinically important genes
12/01/2005US20050266406 Maxs as modifiers of the axin pathway and methods of use
12/01/2005US20050266405 Analysis of apoptotic bodies in bodily fluids
12/01/2005US20050266402 Compositions and methods for binding agglomeration proteins
12/01/2005US20050266401 Compositions and methods for binding agglomeration proteins
12/01/2005US20050266399 HCV regulated protein expression
12/01/2005US20050266398 Method and device for rapid detection and quantitation of macro and micro matrices
12/01/2005US20050266396 Dielectric relaxation spectroscopy apparatus and methods of use
12/01/2005US20050266395 Method and system for morphology based mitosis identification and classification of digital images
12/01/2005US20050266392 Central control system of specimen preservation devices
12/01/2005US20050266246 Inorganic nanocrystals with organic coating layer, their method of manufacture and materials constituted by said nanocrystals
12/01/2005US20050266148 Photocleavable protecting groups and methods for their use
12/01/2005US20050266102 Table of botanical ingredients and method of preparing a table useful for blending combinations thereof
12/01/2005US20050266065 Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance
12/01/2005US20050266022 Methods and compositions for use in the treatment of filovirus mediated disease conditions
12/01/2005US20050266016 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
12/01/2005US20050266013 Diagnosis of RH factor; using polypeptides to form antibodies; purified polypeptide capable of forming antigen binding structures with specificity for Rhesus D antigens for treating idiopathic thrombocytopenic purpura (ITP) or mistransfusion of Rhesus incompatible blood
12/01/2005US20050266009 Antibodies and uses thereof
12/01/2005US20050266004 Anti-human lymphotoxin alpha antibodies, compositions, methods and uses
12/01/2005US20050265999 Modulation of 5-HT2 receptors as a treatment for cardiovascular diseases
12/01/2005US20050265987 Sulfatases and methods of use thereof
12/01/2005US20050265970 Identifying agents which modify mitogen activated kinase activities associated with cell death; small interfering RNA and treament of cell proliferative disorders; for modulating diseases and conditions associated with elevated or decreased apoptosis
12/01/2005US20050265961 Biodegradable poly(beta-amino esters) and uses thereof
12/01/2005US20050265922 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof
12/01/2005US20050265648 Evanescent wave sensor containing nanostructures and methods of using the same
12/01/2005US20050265094 Measuring device and methods for use therewith
12/01/2005US20050264302 Device for determining the composition of a fluid mixture
12/01/2005US20050263790 GaN-based sensor nodes for in situ detection of gases
12/01/2005US20050263693 Multiplexed tandem mass spectrometry
12/01/2005US20050263394 Sensors and sensor arrays of conducting and insulating composites and methods of use thereof
12/01/2005US20050262926 Method and apparatus for determination of medical diagnostics utilizing biological fluids
12/01/2005US20050262924 Calibration device for gas sensors
12/01/2005DE4317098B4 Verfahren zur Detektierung einer inneren Beschädigung in einem FRP-Element Method for detecting an internal damage in an FRP element
12/01/2005DE10335247B4 Verfahren und Vorrichtung zum Abtrennen von Glasplatten Method and device for separating glass sheets
12/01/2005DE102005022022A1 Manufacture of test strips for e.g. blood glucose determination, comprises transferring test fields from prepared test strip band comprising detection film and adhesive tape, onto carrier tape
12/01/2005DE102005021401A1 Verfahren und System zur Feststellung und Überwachung von neurodegenerativen Erkrankungen unter Verwendung von Magnetresonanzspektroskopie Method and system for detection and monitoring of neurodegenerative disorders using magnetic resonance spectroscopy
1 ... 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 ... 3937